Search

Lixin M Zhang

from Morgantown, WV
Age ~57
Get Report
Also known as:
Lixun G Zhang, Lixing Zhang, Lixin Khang, Lisin Zhang, Xin Zhang Li, Zhang Lisin
Related to:
Jianxin X Zhang, 62
Connected to:
Aimei Zhang, 44Aining Zhang, 30Aiqing Zhang, 50Alexia Y Zhang, 36Amy X Zhang, 57Angelina Zhang, 54Ashley C Zhang, 60Baomin Zhang, 55Beilei Zhang, 45Carl Zhang, 33

Lixin Zhang Phones & Addresses

  • Morgantown, WV
  • Bridgeport, WV
  • Houston, TX
  • 262 Bradley St, New Haven, CT 06510 (203) 562-9314
  • Muncie, IN
  • Cambridge, MA
  • Queensbury, NY
  • Braintree, MA
  • Boston, MA
  • Highland Park, NJ

Languages

English

Specialities

Anatomic & Clinical Pathology • Pathology

Professional Records

Medicine Doctors

Lixin Zhang Photo 1

Dr. Lixin Zhang, Glens Falls NY - MD (Doctor of Medicine)

View page
Specialties:
Anatomic & Clinical Pathology
Pathology
Address:
100 Park St, Glens Falls, NY 12801
(518) 926-3840 (Phone), (518) 926-3802 (Fax)

2401 W University Ave, Muncie, IN 47303
(765) 747-4340 (Phone), (765) 747-4466 (Fax)
Languages:
English
Lixin Zhang Photo 2

Lixin Zhang

View page
Specialties:
Neurology
Work:
Dent Neurological Institute
3980 Sheridan Dr, Buffalo, NY 14226
(716) 250-2000 (phone), (716) 250-2045 (fax)
Education:
Medical School
Weifang Med Coll, Weifang City, Shandong, China
Graduated: 1987
Procedures:
Continuous EKG
Hearing Evaluation
Inner Ear Tests
Lumbar Puncture
Neurological Testing
Sleep and EEG Testing
Conditions:
Bell's Palsy
Dementia
Ischemic Stroke
Migraine Headache
Obstructive Sleep Apnea
Languages:
English
Description:
Dr. Zhang graduated from the Weifang Med Coll, Weifang City, Shandong, China in 1987. He works in Amherst, NY and specializes in Neurology. Dr. Zhang is affiliated with Millard Fillmore Suburban Hospital.
Lixin Zhang Photo 3

Lixin Zhang

View page

Business Records

Name / Title
Company / Classification
Phones & Addresses
Lixin Lilly Zhang
BASEPAIR CORPORATION, LLC
Lixin Lilly Zhang
AMERICAN ASSOCIATION OF SCIENCE AND COMMERCE
Lixin Zhang
Director
LIDA PIPE (USA) INC
6863 Turtlewood Dr, Houston, TX 77072
14905 SW Fwy, Sugar Land, TX 77478
Lixin Zhang
Director
TEXAS VICTOR INTERNATIONAL BUSINESS CORP
5925 Sovereign Dr SUITE 22, Houston, TX 77036
Lixin Zhang
Treasurer
Cleopatra International Group, Inc

Publications

Us Patents

Adenoviral Expression Vector Comprising A Cd40L Fusion Protein Adapted To Elicit Cellular Immunity

View page
US Patent:
8119117, Feb 21, 2012
Filed:
Nov 12, 2003
Appl. No.:
10/534605
Inventors:
Albert B. Deisseroth - San Diego CA, US
Lixin Zhang - Muncie IN, US
Assignee:
VAXum, LLC - Manassas VA
International Classification:
A61K 48/00
C12N 15/00
US Classification:
424 932, 424 936, 4241991, 4353201
Abstract:
Provided are adenoviral vectors for generating an immune response to antigen. The vectors comprise a transcription unit encoding a secretable polypeptide, the polypeptide comprising a secretory signal sequence upstream of a tumor antigen upstream of CD40 ligand, which is missing all or substantially all of the transmembrane domain rendering CD40L secretable. Also provided are methods of generating an immune response against cells expressing a tumor antigen by administering an effective amount of the invention vector. Further provided are methods of generating an immune response against cancer expressing a tumor antigen in an individual by administering an effective amount of the invention vector. Still further provided are methods of generating immunity to infection by human papilloma virus (HPV) by administering an effective amount of the invention vector which enocodes the E6 or E7 protein of HPV. The immunity generated is long term.

Composition Comprising An Adenoviral Expression Vector Comprising A Cd40L Fusion Protein For Generating Immune Responses

View page
US Patent:
8236295, Aug 7, 2012
Filed:
Feb 2, 2012
Appl. No.:
13/364370
Inventors:
Albert B. Deisseroth - Potomac MD, US
Lixin Zhang - Houston TX, US
Assignee:
VAXum, LLC - Manassas VA
International Classification:
A61K 48/00
C12N 15/00
US Classification:
424 932, 424 936, 4241991, 4353201
Abstract:
Provided are adenoviral vectors for generating an immune response to antigen. The vectors comprise a transcription unit encoding a secretable polypeptide, the polypeptide comprising a secretory signal sequence upstream of a tumor antigen upstream of CD40 ligand, which is missing all or substantially all of the transmembrane domain rendering CD40L secretable. Also provided are methods of generating an immune response against cells expressing a tumor antigen by administering an effective amount of the invention vector. Further provided are methods of generating an immune response against cancer expressing a tumor antigen in an individual by administering an effective amount of the invention vector. Still further provided are methods of generating immunity to infection by human papilloma virus (HPV) by administering an effective amount of the invention vector which encodes the E6 or E7 protein of HPV. The immunity generated is long term.

Methods Of Generating Immune Responses With Compositions Comprising An Adenoviral Expression Vector Comprising A Cd40L Fusion Protein

View page
US Patent:
8540979, Sep 24, 2013
Filed:
Jul 16, 2012
Appl. No.:
13/549581
Inventors:
Albert B. Deisseroth - Potomac MD, US
Lixin Zhang - Houston TX, US
Assignee:
VAXum, LLC - Manassas VA
International Classification:
A61K 48/00
C12N 15/00
US Classification:
424 932, 4241991, 4353201, 514 44 R
Abstract:
Provided are adenoviral vectors for generating an immune response to antigen. The vectors comprise a transcription unit encoding a secretable polypeptide, the polypeptide comprising a secretory signal sequence upstream of a tumor antigen upstream of CD40 ligand, which is missing all or substantially all of the transmembrane domain rendering CD40L secretable. Also provided are methods of generating an immune response against cells expressing a tumor antigen by administering an effective amount of the invention vector. Further provided are methods of generating an immune response against cancer expressing a tumor antigen in an individual by administering an effective amount of the invention vector. Still further provided are methods of generating immunity to infection by human papilloma virus (HPV) by administering an effective amount of the invention vector which enocodes the E6 or E7 protein of HPV. The immunity generated is long term.

Spar Hull Belly Strake Design And Installation Method

View page
US Patent:
20100192829, Aug 5, 2010
Filed:
Feb 4, 2009
Appl. No.:
12/365811
Inventors:
Michael Y. H. Luo - Bellaire TX, US
Harvey O. Mohr - Katy TX, US
Lixin Zhang - Sugar Land TX, US
Assignee:
TECHNIP FRANCE - Courbevoie
International Classification:
B63B 3/14
B63B 35/44
US Classification:
114285, 114264
Abstract:
A spar hull for a floating vessel can include a hard tank having a belly portion, a fixed strake coupled to the outer surface of the tank and a folding strake coupled to the belly portion of the tank, the folding strake having one or more strake panels and one or more support frames. A method for installing folding belly strakes on a spar hull may include providing a floating spar hull having a hard tank with a belly side, rotating the spar so that the belly side is in a first workable position, coupling at least one folding strake to the belly side of the spar, and coupling the strake in a folded position for transport. The method may include positioning the spar hull offshore in a transport position, upending the spar hull, unfolding the strake, fixing the strake in the unfolded position and installing the spar hull.

Spar Hull Belly Strake Design And Installation Method

View page
US Patent:
20120272888, Nov 1, 2012
Filed:
Jan 28, 2010
Appl. No.:
13/147256
Inventors:
Michael Y.H. Luo - Bellaire TX, US
Harvey O. Mohr - Katy TX, US
Vera Mohr - Carmine TX, US
Lixin Zhang - Sugar Land TX, US
Kostas Filoktitis Lambrakos - Houston TX, US
Assignee:
TECHNIP FRANCE - Courbevoie
International Classification:
B63B 35/44
B63B 3/38
US Classification:
114285
Abstract:
A spar hull for a floating vessel can include a hard tank having a belly portion, a fixed strake coupled to the outer surface of the tank and a folding strake coupled to the belly portion of the tank, the folding strake having one or more strake panels and one or more support frames. A method for installing folding belly strakes on a spar hull may include providing a floating spar hull having a hard tank with a belly side, rotating the spar so that the belly side is in a first workable position, coupling at least one folding strake to the belly side of the spar, and coupling the strake in a folded position for transport. The method may include positioning the spar hull offshore in a transport position, upending the spar hull, unfolding the strake, fixing the strake in the unfolded position and installing the spar hull.

Adenoviral Vector Vaccine

View page
US Patent:
20140080208, Mar 20, 2014
Filed:
Aug 23, 2013
Appl. No.:
13/974353
Inventors:
Albert B. Deisseroth - Potomac MD, US
Lixin Zhang - Houston TX, US
Assignee:
VAXum, LLC - Manassas VA
International Classification:
C07K 14/705
C07K 14/005
US Classification:
4353201
Abstract:
Provided are adenoviral vectors for generating an immune response to antigen. The vectors comprise a transcription unit encoding a secretable polypeptide, the polypeptide comprising a secretory signal sequence upstream of a tumor antigen upstream of CD40 ligand, which is missing all or substantially all of the transmembrane domain rendering CD40L secretable. Also provided are methods of generating an immune response against cells expressing a tumor antigen by administering an effective amount of the invention vector. Further provided are methods of generating an immune response against cancer expressing a tumor antigen in an individual by administering an effective amount of the invention vector. Still further provided are methods of generating immunity to infection by human papilloma virus (HPV) by administering an effective amount of the invention vector which encodes the E6 or E7 protein of HPV. The immunity generated is long term.

Adenoviral Vector Vaccine

View page
US Patent:
20170065705, Mar 9, 2017
Filed:
Sep 13, 2016
Appl. No.:
15/263608
Inventors:
- Warrenton VA, US
Lixin Zhang - Houston TX, US
International Classification:
A61K 39/12
C07K 14/005
C12N 15/86
C07K 14/705
Abstract:
Provided are adenoviral vectors for generating an immune response to antigen. The vectors comprise a transcription unit encoding a secretable polypeptide, the polypeptide comprising a secretory signal sequence upstream of a tumor antigen upstream of CD40 ligand, which is missing all or substantially all of the transmembrane domain rendering CD40L secretable. Also provided are methods of generating an immune response against cells expressing a tumor antigen by administering an effective amount of the invention vector. Further provided are methods of generating an immune response against cancer expressing a tumor antigen in an individual by administering an effective amount of the invention vector. Still further provided are methods of generating immunity to infection by human papilloma virus (HPV) by administering an effective amount of the invention vector which encodes the E6 or E7 protein of HPV. The immunity generated is long term.

Ctc Biomarker Assay To Combat Breast Cancer Brain Metastasis

View page
US Patent:
20140322356, Oct 30, 2014
Filed:
Nov 28, 2012
Appl. No.:
14/361248
Inventors:
- Houston TX, US
Lon Ridgway - Houston TX, US
Lixin Zhang - Houston TX, US
Assignee:
BAYLOR COLLEGE OF MEDICINE - Houston TX
International Classification:
C12Q 1/68
G01N 33/574
US Classification:
424649, 435 723, 435 611, 435 612
Abstract:
Embodiments of the present invention concern methods related to treating, prognosticating and/or diagnosing at least brain metastatic breast cancer. Embodiments of the methods include characterizing circulating tumor cells for the presence or absence of EpCAM and, upon identification of EpCAM negative cells and identification of the status of other markers (such as heparanase and/or Notch1, for example), treating the individual based on the determination of the characterization.
Control profile
Lixin M Zhang from Morgantown, WV, age ~57 Get Report